Methylphenidate in ADDH and Epilepsy
The safety of methylphenidate (MPH), 0.3 mg/kg, in 9 boys and 8 girls, ages 6 to 16 years, with ADHD and epilepsy, studied in Jerusalem, Israel, was reported at the Annual Meeting of the Child Neurology Society, Oct 2-8, 1994, in San Francisco, CA.
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1994-10-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/2719 |